Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Icecure Medical Ltd ICCM

IceCure Medical Ltd, a commercial stage medical device company, researches, develops, and markets cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally. The company offers ProSense system, a single probe system for the treatment of malignant breast tumors, as well as associated disposables; and IceSense3... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (NDAQ:ICCM)

IceCure Reports Financial & Operational Results for the Nine Months Ended September 30, 2025

PR Newswire November 19, 2025

IceCure's ProSense® Cryoablation System Receives Regulatory Approval in Switzerland for Indications Including Breast, Lung, Liver, and Kidney Cancer

PR Newswire November 18, 2025

IceCure Medical Announces Receipt of Nasdaq Minimum Bid Price Notification

PR Newswire November 14, 2025

IceCure Medical to Report Third Quarter 2025 Financial and Operating Results on November 19, 2025

PR Newswire November 12, 2025

IceCure Promotes Shay Levav to Chief Operating Officer as Company Ramps up for Increased Commercial Traction

PR Newswire November 10, 2025

IceCure's Cryoablation System Combined with Radiation Therapy Successfully Treats Non-Small Cell Lung Cancer (NSCLC) with 92% Disease-Specific 5-year Survival

PR Newswire November 3, 2025

IceCure's ProSense® Showcased at TME Fall Summit: "Take the Lead in Breast Cancer Care" Roundtable Highlighting Cryoablation Advances

PR Newswire October 13, 2025

IceCure Medical to Attend the 2025 Maxim Growth Summit

PR Newswire October 9, 2025

IceCure Medical's ProSense® Cryoablation Granted FDA Marketing Authorization for Treatment of Low-Risk Breast Cancer in Women Aged 70 and Above: Significant Development in Giving Women with Breast Cancer Minimally Invasive Care

PR Newswire October 3, 2025

Opinion & Analysis (NDAQ:ICCM)

No current opinion is available.

Bullboard Posts (NDAQ:ICCM)

Buy buddy buy.

Otherwise it will be FOMO for you fellas out there today anyway,so good luck to all of you
coolfooldumbguy - October 6, 2025

ICCM.....1st scalp of the a.m ; )

Call it "Lunch Money" 
Iseneschal - April 15, 2024

An unbelievable N.R. and nothing.

Study Using IceCure's ProSense® Treatment Results in 100% Tumor Reduction in Early-Stage Breast Cancer
billybob22 - February 27, 2024

RE:New Press Release - Study Using IceCure's ProSense&#xAE; Finds: "Cryoablation Allows the Ultimate De-escalation of Surgical Therapy for Select Breast Cancer Patients"

Another great news release but the stock drops..............
billybob22 - December 13, 2023

ICCM .... N.H.O.D $1.49 Tuesday !!!!!!!

That $1.49 could be the next 649 Lotto JMHO
Iseneschal - November 28, 2023

ICCM....Poppin off

Wait for the music
Iseneschal - November 28, 2023